A retrospective analysis of cervical squamous cell carcinoma patients identified post-radiation antigen levels and residual tumor diameter as independent predictors of recurrence and metastasis. In the 215-patient cohort, the authors quantified how biomarker kinetics after radiotherapy and remaining lesion size can stratify risk for later failure. The findings support a model where clinicians can combine tumor geometry with treatment-response biomarkers to refine follow-up intensity and prognostic counseling after definitive radiation.